Financhill
Back

Compagnie Financiere Richemont SA Vs. NovoCure Industry Stock Comparison

Sell
37

CFRUY
Compagnie Financiere Richemont SA

Last Price:
14.61
Seasonality Move:
6.19%
Buy
77

NVCR
NovoCure

Last Price:
28.82
Seasonality Move:
2.04%
Sell
37
Compagnie Financiere Richemont SA (CFRUY) is a Sell

Is Compagnie Financiere Richemont SA a Buy, Sell or Hold?

  • The current Compagnie Financiere Richemont SA [CFRUY] share price is $14.41. The Score for CFRUY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CFRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CFRUY Stock Price Chart

What is Compagnie Financiere Richemont SA's stock price today?

  • The Compagnie Financiere Richemont SA share price today is $14.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFRUY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

CFRUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 59.38 Buy
Chaikin Money Flow: 1451557 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.38 - 14.4) Buy
Bollinger Bands (100): (13.91 - 15.45) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

CFRUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.75 Buy
20-day SMA: 13.72 Buy
50-day SMA: 14.42 Sell
200-day SMA: 15.02 Sell
8-day EMA: 13.91 Buy
20-day EMA: 13.88 Buy
50-day EMA: 14.22 Buy
200-day EMA: 14.65 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

Compagnie Financiere Richemont SA Earnings Growth & CFRUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.01 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Compagnie Financiere Richemont SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):